Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A human bone marrow organoid for disease modelling and drug screening in blood cancers

ABSTRACT: A human bone marrow organoid for disease modelling and drug screening in blood cancers

PROVIDER: PRJNA806847 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18015620.fastq.gz	Fastqsanger.gz
	SRR18015621.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

A human bone marrow organoid for disease modelling and drug screening in blood cancers

Project description:Here we upload data from the 10x analysis of 2 types of human stem cell derived bone marrow organoids.

2022-11-15 | GSE196684 | GEO

Reproducibility of PD patient-specific midbrain organoid data for in vitro disease modelling (passages)

Project description:Midbrain organoids are advanced in vitro cellular models for disease modelling. They have been used successfully over the past decade for Parkinson’s disease (PD) research and drug development. The three-dimensional structure and multicellular composition allow disease research under more physiological conditions than is possible with conventional 2D cellular models. However, there are concerns in the field regarding the organoid batch-to-batch variability and thus the reproducibility of the results. In this manuscript, we generate multiple independent midbrain organoid batches derived from healthy individuals or GBA-N370S mutation-carrying PD patients to evaluate the reproducibility of the GBA-N370S mutation-associated PD transcriptomic and metabolic signature as well as selected protein abundance. Our analysis shows that GBA-PD-associated phenotypes are reproducible across organoid generation batches and time points. This proves that midbrain organoids are not only suitable for PD in vitro modelling, but also represent robust and highly reproducible cellular models.

2025-07-08 | GSE287566 | GEO

Reproducibility of PD patient-specific midbrain organoid data for in vitro disease modelling (timepoints)

2025-09-18 | GSE269316 | GEO

Modelling complex cardiovascular disease in mature organoid model

Project description:Cardiac maturation is an important developmental phase where there are profound biological and functional changes after birth in mammals. Herein, we use our profiling of human heart maturation in vivo to identify key drivers of maturation in our human cardiac organoid (hCO) model. In this dataset, we exemplified the applicability of our mature organoids in modelling cardiovascular disease. Pathogenesis of Desmoplakin (DSP) cardiomyopathies are driven by complex cellular interplay and changes in excitation-contraction coupling. A patient (MCHTB11), was screened against a 202 cardiac gene panel for clinically-relevant rare DNA variants (frequency < 0.04%). A homozygous 2 bp deletion was identified in the DSP gene, and recapitulated in our hCOs utilising CRISPR. In this screen, we also utilised INCB054329, a bromodomain extra-terminal inhibitor, to suppress diastolic dysfunction induced by the DSP mutant. In this dataset, we evaluate the proteomic remodelling induced by DSP-mutants (DSP) versus recovered mutants (CTRL), with and without INCB (n=3-4 for each group).

2025-04-17 | PXD054791 | Pride

A comparative study of drug screening results based on organoid technology and clinical guideline recommendations in colorectal cancer liver metastasis

Project description:Interventions: test group:Drugs based on organoid drug screening results;control group:Standard second-line drugs Primary outcome(s): ORR Study Design: Parallel

| 84968 | ecrin-mdr-crc

Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors

Project description:Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors

| PRJNA740252 | ENA

Trellis Single-Cell Screening Reveals Stromal Regulation of Patient-Derived Organoid Drug Responses

Project description:Trellis Single-Cell Screening Reveals Stromal Regulation of Patient-Derived Organoid Drug Responses

| PRJNA999180 | ENA

An organoid screening framework to engineer intestinal epithelial composition

Project description:An organoid screening framework to engineer intestinal epithelial composition

| PRJNA624878 | ENA

3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening.

Project description: Not available

| S-EPMC6279764 | biostudies-literature

Human Retinal Organoid Model of Disease-Relevant Photoreceptor Cell Death Amenable to Drug Screening

Project description:Dry age-related macular degeneration (AMD) is characterized by the progressive loss of retinal pigment epithelium cells in the macula, leading to photoreceptor degeneration and loss of central vision. Current treatments can only slow disease progression in some cases, but once photoreceptors are damaged, vision loss becomes irreversible. Therefore, there is an urgent need to develop therapies that prevent photoreceptor cell death. A critical step toward this goal is establishing pathophysiologically relevant human disease models for therapeutic testing. In this study, we developed a human- induced pluripotent stem cell-derived retinal organoid (RO) model that recapitulates key aspects of AMD-associated photoreceptor degeneration. Since cigarette smoking is a major environmental risk factor for AMD, we exposed ROs to cigarette smoke extract (CSE) to induce cellular stress. CSE treatment resulted in increased reactive oxygen species, mitochondrial membrane depolarization, and cell death primarily in the outer nuclear layer. Photoreceptor degeneration in this model involves the activation of the intrinsic apoptotic pathway and ferroptosis, which is accompanied by lipid peroxidation and dysregulation of the glutathione system. Comprehensive proteomic analysis confirmed the dysregulation of metabolic and stress response pathways. The integration of this model with robust, quantitative outcome measures in live ROs offers a powerful platform for preclinical drug screening and therapeutic evaluation.

2026-04-14 | PXD063075 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data